The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.
With the New Consumer Agenda, the European Commission wants consumers to be key drivers in the green and digital transitions and key actors in the economic recovery.
Memo ta’ informazzjoni: Teleworking and gender equality - conditions so that teleworking does not exacerbate the unequal distribution of unpaid care and domestic work between women and men and for it to be an engine for promoting gender equality
This Own Initiative opinion aims to define the special impacts of AI on liberal professional services, the changes of professional profiles and the resultant adaptation requirements in regard to (professional) regulation, professional conduct, professional qualification and training, (financial) supporting measures, infrastructure etc.
In September 2020, the European Commission presented the Action Plan on Critical Raw Materials, which also contains the 2020 List of Critical Raw Materials.
This proposal is the first of a set of measures announced in the 2020 European strategy for data.